GH Research (GHRS) Total Current Liabilities (2021 - 2025)

GH Research's (GHRS) quarterly Total Current Liabilities came in at $8.4 million in Q4 2025, down 6.4% year-on-year from $9.0 million in Q4 2024, and down 19.49% quarter-over-quarter from $10.4 million in Q3 2025.

GH Research (GHRS) Total Current Liabilities (2021 - 2025) Analysis & Trends

GH Research's Total Current Liabilities history runs 5 years deep, the most recent figure standing at $8.4 million for Q4 2025.

  • On a quarterly basis, Total Current Liabilities fell 6.4% year-over-year to $8.4 million in Q4 2025; TTM through Dec 2025 was $8.4 million, a 6.4% decrease from a year earlier, with the FY2025 full-year figure at $8.4 million, down 6.4% from the prior year.
  • Total Current Liabilities fell to $8.4 million in Q4 2025 per GHRS's latest filing, from $10.4 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $10.4 million in Q3 2025 and bottomed at $2.0 million in Q3 2021.
  • The 5-year median for Total Current Liabilities is $6.7 million (2023), against an average of $6.6 million.
  • Across the five-year window, Total Current Liabilities jumped 111.86% in 2023 and declined 6.4% in 2025, its largest moves.
  • Year by year, Total Current Liabilities stood at $3.4 million in 2021, then jumped by 34.42% to $4.5 million in 2022, then surged by 47.4% to $6.7 million in 2023, then jumped by 33.61% to $9.0 million in 2024, then dropped by 6.4% to $8.4 million in 2025.
  • Per Business Quant, the three latest GHRS Total Current Liabilities figures stand at $8.4 million (Q4 2025), $10.4 million (Q3 2025), and $10.0 million (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 56.01 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 66.94 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.81 Bn
4 NuCana 279.75 Bn 279.75 Bn - 6.38 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 3.88 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 5.11 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.58 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 289.60 Mn
10 GH Research 1.69 Bn 1.69 Bn - 8.38 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 8.38 Mn
Sep 30, 2025 10.41 Mn
Jun 30, 2025 9.97 Mn
Mar 31, 2025 9.92 Mn
Dec 31, 2024 8.95 Mn
Sep 30, 2024 9.79 Mn
Jun 30, 2024 7.80 Mn
Mar 31, 2024 7.28 Mn
Dec 31, 2023 6.70 Mn
Sep 30, 2023 6.13 Mn
Jun 30, 2023 6.56 Mn
Mar 31, 2023 6.64 Mn
Dec 31, 2022 4.55 Mn
Sep 30, 2022 3.39 Mn
Jun 30, 2022 3.10 Mn
Mar 31, 2022 4.07 Mn
Dec 31, 2021 3.38 Mn
Sep 30, 2021 2.03 Mn